Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
Annals of Internal Medicine|September 15, 1993
Levothyroxine therapy in patients with thyroid diseaseS J Mandel, G A Brent, P R Larsen
Thyroid : Official Journal of the American Thyroid Association|January 1, 1994
Review of antithyroid drug use during pregnancy and report of a case of aplasia cutisS J Mandel, G A Brent, P R Larsen
Thyroid : Official Journal of the American Thyroid Association|April 1, 1995
Prospective studies of thyroid function in patients receiving gold therapyS J Mandel, G A Brent, M Weinblatt, et al.
The New England Journal of Medicine|July 12, 1990
Increased need for thyroxine during pregnancy in women with primary hypothyroidismS J Mandel, P R Larsen, E W Seely, et al.
Molecular Endocrinology (Baltimore, Md.)|October 1, 1993
Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specificA M Zavacki, J W Harney, G A Brent, et al.
Molecular Endocrinology (Baltimore, Md.)|September 1, 1988
Multihormonal regulation of the human, rat, and bovine growth hormone promoters: differential effects of 3',5'-cyclic adenosine monophosphate, thyroid hormone, and glucocorticoidsG A Brent, J W Harney, D D Moore, et al.
Endocrinology|July 1, 1996
Structural features of thyroid hormone response elements that increase susceptibility to inhibition by an RTH mutant thyroid hormone receptorA M Zavacki, J W Harney, G A Brent, et al.
The Journal of Biological Chemistry|January 5, 1989
Functional characterization of the rat growth hormone promoter elements required for induction by thyroid hormone with and without a co-transfected beta type thyroid hormone receptorG A Brent, P R Larsen, J W Harney, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Thyroid hormone receptor binds to a site in the rat growth hormone promoter required for induction by thyroid hormoneR J Koenig, G A Brent, R L Warne, et al.
Molecular Endocrinology (Baltimore, Md.)|October 1, 1992
Differential capacity of wild type promoter elements for binding and trans-activation by retinoic acid and thyroid hormone receptorsG R Williams, J W Harney, D D Moore, et al.
Pageof 21